Clinical Trial Detail

NCT ID NCT02215512
Title Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors EpicentRx, Inc.
Indications
Therapies

RRx-001

Age Groups: adult

No variant requirements are available.